IRCT20220122053792N1招募中1 期
Evaluation of the effect of Eplerenone in Central serous chorioretinopathy )CSCR
Oroumia University of Medical Sciences0 个研究点目标入组 34 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Patients with chronic central serous chorioretinopathy
排除标准
- •Elevated potassium levels in preoperative blood testsor
- •contraindications in comprehensive medical examination
- •renal impairment
- •severe hepatic impairment
- •known allergies to any of the components of the drug
研究者
相似试验
招募中
3 期
Evaluation of the effect of oral eplerenone in the management of Acute Central Serous ChorioretinopathyAcute Central Serous Chorioretinopathy.Separation of retinal layersH35.7IRCT20220423054621N1Bagheiat-allah University of Medical Sciences20
进行中（未招募）
1 期
REMODEL-AMIEUCTR2014-005407-24-CZIKEM
已完成
不适用
Investigation of an efficacy of eplerenone combined therapy for hypertensive patients with chronic kidney disease that enough hypotensive effect are not obtained with an angiotensin receptor blockerHypertensive patients with chronic kidney disease that enough hypotensive effect is not obtained with an angiotensin receptor blockerJPRN-UMIN000005956OWASE study Project Office200
已完成
不适用
The Multicenter Study for Effects of Eplerenone on Cardiac Diastolic Dysfunction in Hypertensive PatientsHypertensive patients with cardiac diastolic dysfunction and preserved ejection fractionJPRN-UMIN000006415Graduate School of Medical Sciences, Kumamoto University180
招募中
4 期
Comparative study of eplerenone-based treatment strategy versus irbesartan-based blood pressure lowering in obese hypertensive patients (HEBRO Study)Hypertension2024-519749-31-00Institute For Study Research Education And Therapy Of Vascular Heart Brain And Kidney Nosologies198